Endometriosis-Associated Ovarian Cancer: A Clinicopathologic Review

Journal of Obstetrics and Gynaecology Canada

Volumn 26, Issue 8, 2004, Pages 709-715

  Steed, Helen ^a   Chapman, William ^b   Laframboise, Stephane ^a  

^a Division of Gynecologic Oncology   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

Carcinoma endometrioid; Endometrial neoplasms; Endometriosis; Ovarian neoplasms; Radiotherapy

Indexed keywords

ANTINEOPLASTIC METAL COMPLEX; ASPARAGINE; ASPARTIC ACID; BIOLOGICAL MARKER; CARBOPLATIN; ESTROGEN; GALACTOSE I PHOSPHATE URIDYLTRANSFERASE; GESTAGEN; HEXOSE 1 PHOSPHATE URIDYLYLTRANSFERASE; MELPHALAN; PACLITAXEL; UNCLASSIFIED DRUG;

ABDOMINAL HYSTERECTOMY; AGE DISTRIBUTION; ALLELIC IMBALANCE; ARTICLE; CANCER GRADING; CANCER HORMONE THERAPY; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; CHEMORADIOTHERAPY; CLEAR CELL CARCINOMA; CLINICAL FEATURE; CYTOTOXICITY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; ENDOMETRIOSIS; ENDOMETRIOSIS-ASSOCIATED OVARIAN CANCER; ENZYME ACTIVITY; ENZYME DEFECT; FEMALE INFERTILITY; GALACTOSEMIA; GALT GENE; GENE; GENE DELETION; GENE MUTATION; GENETIC RISK; GSTM1 GENE; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; MALIGNANT TRANSFORMATION; MEDICAL HISTORY; MENSTRUATION DISORDER; OOCYTE; OVARY CANCER; OVARY CARCINOMA; OVERALL SURVIVAL; PELVIC PAIN; POSTMENOPAUSE; PREMATURE OVARIAN FAILURE; PTEN GENE; RISK FACTOR; RISK REDUCTION; SALPINGOOOPHORECTOMY; TUMOR SUPPRESSOR GENE; ADENOCARCINOMA; ADULT; CELL TRANSFORMATION; ENDOMETRIOID CARCINOMA; FEMALE; GENETICS; INFERTILITY; OVARY TUMOR; PATHOLOGY; PELVIS PAIN SYNDROME; PRECANCER; REVIEW;

ADENOCARCINOMA, CLEAR CELL; ADULT; CARCINOMA, ENDOMETRIOID; CELL TRANSFORMATION, NEOPLASTIC; ENDOMETRIOSIS; FEMALE; HUMANS; INFERTILITY; OVARIAN NEOPLASMS; PELVIC PAIN; PRECANCEROUS CONDITIONS;

EID: 7944233129     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)30642-9     Document Type: Article

References (48)

1. Stenchever MA, Droegemueller W, Herbst AL, Mishell DR Comprehensive gynecology 2001, Mosby Year Book, St Louis. 4th ed.
2. Seidman JD Prognostic importance of hyperplasia and atypia in endometriosis. Int J Gynecol Pathol 1996, 15:1-9.
3. Berek JS, Hacker NF Practical gynecologic oncology 2000, Lippincott Williams & Wilkins, Philadelphia. 3rd ed.
4. McMeekin DS, Burger RA, Manetta A, DiSaia P, Berman ML Endometrioid adenocarcinoma of the ovary and its relationship to endometriosis. Gynecol Oncol 1995, 59:81-86.
5. Goumenou AG, Arvanitis DA, Matalliotakis IM, Koumantakis EE, Spandidos DA, Microsatellite DNA assays reveal an allelic imbalance in p 16(lnk4), GALT, p53, and APOA2 loci in patients with endometriosis. Fertil Steril 2001, 75:160-165.
6. Obata K Morland SJ,Watson RH, Hitchcock A, Chenevix-Trench G, Thomas EJ, et al. Frequent PTEN/MMAC mutations in endometrioid, but not serous or mucinous epithelial ovarian tumours. Cancer Res 1998, 58:2095-2097.
7. Fukunaga M, Nomura K, Ishikawa E, Ushigome S Ovarian atypical endometriosis: its close association with malignant epithelial tumours. Histopathology 1997, 30:249-255.
8. Valle RF, Sciarra JJ Endometriosis: treatment strategies. Ann N Y Acad Sci 2003, 997:229-239.
9. Sampson J Endometrial carcinoma of the ovary, arising in endometrial tissue of that organ. Arch Surg 1925, 10:1-72.
10. Swiersz LM Role of endometriosis in cancer and tumor development. Ann NY Acad Sci 2002, 955:281-292.
11. Giudice LC, Taxuke SI, Swiersz L Status of current research on endometriosis. J Reprod Med 1998, 43(3):252-262.
12. Brinton LA, Gridley G, Persson I, Baron J, Bergqvist A Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 1997, 176:572-579.
13. Ozols RE Update on the management of ovarian cancer. Cancer J 2002, 8(1):S22-S30.
14. Aure J, Hoeg K, Kolstad P Carcinoma of the ovary and endometriosis. Acta Obstet Gynecol Scand 1971, 50:63-67.
15. Heaps JM, Nieberg RK, Berek JS Malignant neoplasms arising in endometriosis. Obstet Gynecol 1990, 75:1023-1028.
16. Kline RC, Wharton JT, Atkinson EN, Burke TW, Gershenson DM Edwards CL Endometrioid carcinoma of the ovary: retrospective review of 145 cases. Gynecol Oncol 1990, 39:337-346.
17. Sainz de la Cuesta R, Eichhorn JH, Rice LW, Fuller AF, Nikrui N, Goff BA Histologic transformation of benign endometriosis to early epithelial ovarian cancer. Gynecol Oncol 1996, 60:238-244.
18. Brooks JJ, Wheeler JE Malignancy arising in extragonadal endometriosis: a case report and summary of the word literature. Cancer 1977, 40:3065-3073.
19. Mostoufizadeh M, Scully RE Malignant tumours arising in endometriosis. Clin Obstet Gynecol 1980, 23:951-963.
20. Chen YT, Mattison DR, Feigenbaum L, Fukui H, Schulman JD Reduction in oocyte number following prenatal exposure to a diet high in galactose. Science 1981, 214:1145-1147.
21. Cramer DW, Muto MG, Reichardt JK, Xu H, Welch WR, Valles B, et al. Characteristics of women with a family history of ovarian cancer: I. Galactose consumption and metabolism. Cancer 1994, 74:1309-1317.
22. Cramer DW, Goldstein DP, Fraer C, Reichardt JK Vaginal agenesis (Mayer-Rokitansky-Kuster-Hauser syndrome) associated with the N314D mutation of galactose-1-phosphate uridyl transferase (GALT). Mol Hum Reprod 1996, 2:145-148.
23. Ulrich AB, Standop J, Schmied BM, Schneider MB, Lawson TA, Pour PM Species differences in the distribution of drug-metabolizing enzymes in the pancreas. Toxicol Pathol 2002, 30(2):247-253.
24. Baranov VS, Ivaschenko T, Bakay B, Aseev M, Belotserkovskaya R, Baranova H, et al. Proportion of the GSTMI 0/0 genotype in some Slavic populations and its correlation with cystic fibrosis and some multifactorial diseases. Hum Genet 1996, 97:516-520.
25. Baranova H, Bothorishvilli HR, Canis M, Albuisson E, Perriot S, Glowaczower E, et al. Glutathione S-transferase MI gene polymorphism and susceptibility to endometriosis in a French population. Mol Hum Reprod 1997, 3:775-780.
26. Baxter SW, Thomas EJ, Campbell IG GSTM I null polymorphism and susceptibility to endometriosis and ovarian cancer. Carcinogenesis 2001, 22:63-65.
27. Simpson L, Parsons R PTEN: life as a tumor suppressor. Exp Cell Res 2001, 264:29-41.
28. Di Cristofano A Pandolfi PRThe multiple roles of PTEN in tumor suppression. Cell 2000, 100:387-390.
29. Sato N, Tsunoda H, Nishida M, Morishita Y, Takimoto Y, Kubo T, et al. Loss of heterozygosity on 10q23.3 and mutation of the tumour suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res 2000, 60:7052-7056.
30. Erzen M, Rakar S, Klancar B, Syrjanen K Endometriosis-associated ovarian carcinoma: an entity distinct from other ovarian carcinomas as suggested by a nested case-control study. Gynecol Oncol 2001, 83:100-108.
31. Modesitt SC, Tortolero-Luna G, Robinson JB, Gershenson DM, Wolf JK Ovarian and extraovarian endometriosis-associated cancer. Obstet Gynecol 2002, 100:788-795.
32. Vercellini P, Scarfone G, Bolis G, Stellato G, Carinelli S, Crosignani PG Site of origin of epithelial ovarian cancer: the endometriosis connection. Br J Obstet Gynaecol 2000, 107:1155-1157.
33. Thomas EJ, Campbell IG Evidence that endometriosis behaves in a malignant manner. Gynecol Obstet Invest 2000, 50(1):2-10.
34. Changes in definitions of clinical staging for carcinoma of the cervix and ovary: International Federation of Gynecology and Obstetrics. Am J Obstet Gynecol 1987;156(1):263-4.
35. Czernobilsky B, Morris WJ A histologic study of ovarian endometriosis with emphasis on hyperplastic and atypical changes. Obstet Gynecol 1979, 53:318-323.
36. Ogawa S, Kaku T, Amada S, Kobayashi H, Girakawa T, Ariyoshi K, et al. Ovarian endometriosis associated with ovarian carcinoma: a clinico-pathological and immunohistochemical study. Gynecol Oncol 2000, 77:298-304.
37. La Grenade A, Silvergerg SG Ovarian tumors associated with atypical endometriosis. Hum Pathol 1988, 19:1080-1084.
38. Chapman WB Developments in the pathology of ovarian tumours. Curr Opin Obstet Gynecol 2001, 13:53-59.
39. Jiang X, Morland SJ, Hitchcock A, Thomas EJ, Campbell IG Allelotyping of endometriosis with adjacent ovarian carcinoma revealed evidence of a common lineage. Cancer Res 1998, 58:1707-1712.
40. Pokieser W, Schmerker R, Kisser M, Peters-Engl C, Muhlbauer H, Ulrich W Clear cell carcinoma arising in endometriosis of the rectum following progestin therapy. Pathol Res Pract 2002, 198:121-124.
41. Stern RC, Dash R, Bentley RC, Snyder MJ, Haney AF, Robboy SJ Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types. Int J Gynecol Pathol 2001, 20:133-139.
42. Yantiss RK, Clement PBJung RH Neoplastic and preneoplastic changes in gastrointestinal endometriosis. Am J Surg Pathol 2000, 24:513-524.
43. Fauconnier A, Chapron C Dubuisson JB,Vieira M, Dousset B, Breart G. Relation between pain symptoms and the anatomic location of deep infiltrating endometriosis. Fertil Steril 2002, 78(4):719-726.
44. Berkowitz RS, Ehrmann RL, Knapp RC Endometrial stromal sarcoma arising from vaginal endometriosis. Obstet Gynecol 1978, 51:34s-37s.
45. Reimnitz C, Brand E, Nieberg RK, Hacker NF Malignancy arising in endometrioisis associated with unopposed estrogen replacement. Obstet Gynecol 1988, 71:444-447.
46. Dembo AJ Abdominopelvic radiotherapy in ovarian cancer: a 10-year experience. Cancer 1985, 55:2285-2290.
47. Dembo AJ, Davy M, Stenwig AE, Berle EJ, Bush RS, Kjorstad K Prognostic factors in patients with stage I epithelial ovarian cancer. Obstet Gynecol 1990, 75:263-273.
48. Firat S, Murray K, Erickson B High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: long-term toxicity and outcomes. Int J Radiat Oncol Biol Phys 2003, 57:210-217.